OneVax (United States)

Research works: 2
Citations: 33
Top-10% rate: 0.0%
Open access: 38%
International: 34%

Not ranked overall: OneVax (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does OneVax (United States) work in?

In all years, 88% of research at OneVax (United States) is in Life Sciences, 12% in Health Sciences. Its largest fields are Immunology and Microbiology (41%), Neuroscience (41%), Medicine (12%). It does 1.4× the world's share of Life Sciences.

Life Sciences88%Health Sciences12%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers

Life Sciences288.2%
1. Immunology and Microbiology141.2%
2. Neuroscience141.2%
3. Biochemistry, Genetics and Molecular Biology05.9%
Health Sciences011.8%
1. Medicine011.8%

All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from OneVax (United States)?

The most cited paper from OneVax (United States) is "Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model" (Jamal S. Lewis, Joshua Michael Stewart, Gregory P. Marshall et al., 2019), with 85 citations. Next come "Clinical Applications of Regulatory T cells in Adoptive Cell Therapies" (16) and "Microglia Isolation from Neural Stem Cell-Enriched Regions" (0).

Most cited papers
#	Paper	Released	Citations
1	Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model Jamal S. Lewis, Joshua Michael Stewart, Gregory P. Marshall et al. · ACS Biomaterials Science & Engineering Open access	26 Mar 2019	85
2	Clinical Applications of Regulatory T cells in Adoptive Cell Therapies Gregory P. Marshall, Judit Cserny, Daniel J. Perry et al. · Cell and Gene Therapy Insights Open access	30 May 2018	16
3	Microglia Isolation from Neural Stem Cell-Enriched Regions Gregory P. Marshall · Methods in molecular biology Book chapter	24 Sep 2021	0

All 3 most cited papers, with filters and sorting

Which research topics does OneVax (United States) publish most on?

By volume in 2022-now: vaccines and immunoinformatics approaches, Monoclonal and Polyclonal Antibodies Research and Biosimilars and Bioanalytical Methods.

1 vaccines and immunoinformatics approaches Molecular Biology 0 works
2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
3 Biosimilars and Bioanalytical Methods Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

38%62%

openly available37.9%not open62.1%

World: 40% of research is openly available.

34%66%

with international co-authors33.8%domestic only66.2%

World: 18% is written across borders.

How has OneVax (United States)'s research output changed?

Output in 2022-2025 was 100% lower than in 2018-2021.

Other research institutions in Alachua

All research institutions in Alachua

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about OneVax (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.